Previous studies found that ID1 is upregulated by some tumor-derived factors, such as transforming growth factor beta (TGFβ), in bone marrow-derived myeloid cells to promote the myeloid cell differentiation switch from dendritic cells (DCs) to MDSCs via downregulating Irf8 during tumor progression22. This evidence concerns the gene ID1 and neoplasm.